Australia’s peptide research community has grown considerably over the past few years. With more laboratories, independent researchers, and institutions actively sourcing compounds domestically, the question of which peptides are worth prioritising in 2026 comes up often. This roundup covers the most in-demand research peptides currently available at Australian Peptides — all in stock, all dispatching domestically within 24 hours.
Retatrutide
Retatrutide (LY3437943) is arguably the most talked-about peptide in metabolic research right now. As a triple-receptor agonist targeting GLP-1, GIP, and the glucagon receptor simultaneously, it represents a significant step beyond earlier dual-agonist compounds. Research interest has been intense throughout 2024 and 2025, and that momentum has carried into 2026. If your research touches metabolic pathways, energy regulation, or appetite signalling, retatrutide belongs on your list.
In stock · Domestic dispatch available
Semaglutide
Semaglutide remains one of the most referenced GLP-1 receptor agonist peptides in the current literature. Its well-documented receptor binding profile and extensive published research base make it a staple for metabolic and glucose homeostasis investigations. Consistently in demand, consistently in stock.
Tirzepatide
A dual GLP-1 and GIP receptor agonist, tirzepatide sits between semaglutide and retatrutide in terms of receptor engagement complexity. It has generated a substantial volume of research output over the past two years and remains highly sought after by Australian researchers working in the metabolic space.
BPC-157
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It has been the subject of research across tissue repair, gut biology, and inflammatory pathway contexts for decades. One of the most consistently purchased peptides in the Australian market, BPC-157 appeals to a broad range of research applications and is a reliable staple in any well-stocked laboratory.
In stock · Domestic dispatch available
GHK-Cu
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide with one of the longest research histories of any compound in this list. It has been studied extensively across wound biology, skin research, anti-inflammatory pathways, antioxidant activity, and more recently, gene expression. The breadth of its published literature makes it one of the more versatile compounds available for research purposes.
In stock · Domestic dispatch available
TB-500 (Thymosin Beta-4)
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research interest has focused on its role in actin regulation, cellular migration, and tissue repair contexts. It is frequently studied alongside BPC-157, and the two are among the most consistently ordered peptides in the Australian Peptides catalogue.
In stock · Domestic dispatch available
AOD-9604
AOD-9604 is a modified fragment of human growth hormone (hGH), specifically the C-terminal region. Research has examined its behaviour in fat metabolism contexts, distinguishing it from full hGH peptides by its more targeted receptor interaction profile. It has maintained steady research interest in Australia and internationally.
Ipamorelin / CJC-1295
Ipamorelin is a selective growth hormone secretagogue, and CJC-1295 is a GHRH analogue — the two are frequently studied in combination due to their complementary mechanisms. Research applications span growth hormone axis investigation, sleep studies, and metabolic research. Both are available individually and as a research blend.
Why Buy Peptides in Australia From Australian Peptides?
The case for domestic sourcing comes down to a few practical realities that any active researcher will recognise:
- No customs delays — international peptide shipments can be held for weeks, or not arrive at all
- Cold-chain integrity — domestic transit is shorter and more controlled, reducing degradation risk
- 24-hour dispatch — orders placed today ship tomorrow, not in three weeks
- Batch documentation — available on request for research verification purposes
- Australian-based support — real assistance from people who understand the local research environment
Stay Ahead of Stock
High-demand compounds like retatrutide and tirzepatide can move quickly. If a particular peptide is central to your current research protocol, securing stock sooner rather than later is advisable. The Australian Peptides catalogue is updated in real time — visit the store to check current availability across the full range.
Shop the full catalogue at australianpeptides.com.